Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 4:44 pm Sale |
2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
GENERAL ATLANTIC L.P. | 807,997 2.400% |
-1,981,160 (-71.03%) |
Filing History |
| 2023-02-10 4:16 pm Sale |
2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Senator Investment Group LP | 158,105 0.440% |
-1,756,775 (-91.74%) |
Filing History |
| 2023-02-10 12:33 pm Purchase |
2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
ARK Investment Management LLC | 3,609,602 10.660% |
439,130 (+13.85%) |
Filing History |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
The Vanguard Group | 2,538,032 7.490% |
2,538,032 (New Position) |
Filing History |
| 2023-01-24 8:35 pm Sale |
2022-12-22 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
Reshma P. Shetty | 4,894,713 12.000% |
-523,294 (-9.66%) |
Filing History |
| 2023-01-24 8:19 pm Sale |
2023-01-24 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
Kelly Jason R | 2,425,436 6.200% |
-271,324 (-10.06%) |
Filing History |
| 2023-01-23 11:31 am Purchase |
2022-12-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
BAILLIE GIFFORD & CO | 6,104,416 18.030% |
1,910,599 (+45.56%) |
Filing History |
| 2022-10-11 1:03 pm Purchase |
2022-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
ARK Investment Management LLC | 3,170,471 10.640% |
3,170,471 (New Position) |
Filing History |
| 2022-10-04 9:51 pm Purchase |
2022-10-01 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
Kelly Jason R | 2,696,759 8.500% |
632,232 (+30.62%) |
Filing History |
| 2022-10-04 9:51 pm Purchase |
2022-10-01 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
Reshma P. Shetty | 5,418,007 16.000% |
1,266,964 (+30.52%) |
Filing History |
| 2022-07-01 5:00 pm Purchase |
2022-06-28 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
VIKING GLOBAL INVESTORS LP | 2,877,103 9.700% |
1,600,725 (+125.41%) |
Filing History |
| 2022-04-06 07:10 am Purchase |
2022-03-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
BAILLIE GIFFORD & CO | 4,193,817 15.530% |
1,221,927 (+41.12%) |
Filing History |
| 2022-03-04 5:21 pm Sale |
2022-03-02 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
VIKING GLOBAL INVESTORS LP | 1,276,379 4.990% |
-6,297,196 (-83.15%) |
Filing History |
| 2022-02-14 8:00 pm Sale |
2021-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Austin Che | 2,073,022 5.900% |
-2,500 (-0.12%) |
Filing History |
| 2022-02-14 7:57 pm Sale |
2021-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Knight Thomas F. Jr. | 1,877,076 5.700% |
-2,500 (-0.13%) |
Filing History |
| 2022-02-14 4:21 pm Purchase |
2021-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Anchorage Capital Group L.L.C. | 1,730,209 5.280% |
1,730,209 (New Position) |
Filing History |
| 2022-02-14 06:22 am Purchase |
2021-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Citadel Advisors LLC | 29,294 0.100% |
29,294 (New Position) |
Filing History |
| 2022-02-11 3:13 pm Sale |
2021-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
GENERAL ATLANTIC L.P. | 2,789,157 8.500% |
-81,759 (-2.85%) |
Filing History |
| 2022-02-10 4:32 pm Sale |
2021-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Senator Investment Group LP | 1,914,880 5.800% |
-88,952 (-4.44%) |
Filing History |
| 2022-02-03 11:29 am Purchase |
2022-01-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
BAILLIE GIFFORD & CO | 2,971,890 10.000% |
235,635 (+8.61%) |
Filing History |